{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:18:18Z","timestamp":1785827898976,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtm.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T06:17:30Z","timestamp":1687155450000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-4139","authenticated-orcid":false,"given":"Manuela","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-1756","authenticated-orcid":false,"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim S.","family":"Tuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary I.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Barbouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng1093-118","article-title":"Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease","volume":"5","author":"Kaul","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2023.06.001_bib2","series-title":"Canavan Disease. StatPearls. Treasure","author":"Bokhari","year":"2021"},{"key":"10.1016\/j.omtm.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omtm.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13023-020-01659-3","article-title":"The natural history of Canavan disease: 23 new cases and comparison with patients from literature","volume":"16","author":"Bley","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ped.12422","article-title":"Canavan disease: clinical features and recent advances in research","volume":"56","author":"Hoshino","year":"2014","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.omtm.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1089\/104303402760128612","article-title":"Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain","volume":"13","author":"Janson","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1531-8249(200007)48:1<27::AID-ANA6>3.0.CO;2-6","article-title":"Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease","volume":"48","author":"Leone","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2019.00724","article-title":"Gene therapy tools for brain diseases","volume":"10","author":"Ingusci","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtm.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/mt.2013.138","article-title":"A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice","volume":"21","author":"Ahmed","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/8904_2014_356","article-title":"Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades","volume":"19","author":"Ahmed","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.omtm.2023.06.001_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90807","article-title":"Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease","volume":"2","author":"Gessler","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2023.06.001_bib13","first-page":"318","article-title":"Disease specific neurometabolic pathways are corrected in an age-dependent manner independent of rAAV gene delivery efficacy","volume":"28","author":"Gessler","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/humc.2017.146","article-title":"Safety of intradiaphragmatic delivery of adeno-associated virus-mediated alpha-glucosidase (rAAV1-CMV-hGAA) gene therapy in children affected by Pompe disease","volume":"28","author":"Corti","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2023.06.001_bib16","series-title":"Bayley Scales of Infant and Toddler Development. StatPearls. Treasure","author":"Balasundaram","year":"2021"},{"key":"10.1016\/j.omtm.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2023.06.001_bib18","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.apmr.2013.04.001","article-title":"Motor function measure: validation of a short form for young children with neuromuscular diseases","volume":"94","author":"de Lattre","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.omtm.2023.06.001_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jphys.2017.05.007","article-title":"The Gross Motor Function Measure (GMFM)","volume":"63","author":"Harvey","year":"2017","journal-title":"J.\u00a0Physiother."},{"key":"10.1016\/j.omtm.2023.06.001_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nic.2012.12.001","article-title":"Normal myelination: a practical pictorial review","volume":"23","author":"Branson","year":"2013","journal-title":"Neuroimaging Clin."},{"key":"10.1016\/j.omtm.2023.06.001_bib21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3174\/ajnr.A0751","article-title":"Early postnatal development of corpus callosum and corticospinal white matter assessed with quantitative tractography","volume":"28","author":"Gilmore","year":"2007","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omtm.2023.06.001_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41467-022-28326-4","article-title":"White matter myelination during early infancy is linked to spatial gradients and myelin content at birth","volume":"13","author":"Grotheer","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.06.001_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.omtm.2023.06.001_bib24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV gene transfer to the nervous system: a clinical reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2023.06.001_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","article-title":"A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna","volume":"28","author":"Taghian","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.omtm.2023.06.001_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular delivery as a safe, long-term route of drug administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.omtm.2023.06.001_bib28","unstructured":"Scott DW, Rouse JL, Romero KB, Eclov R, Lewis TEW, Kapadia M, Mansfield G, Beard CW, editors. A route of administration study of BBP-812, an AAV9-based gene therapy for the treatment of Canavan disease, in juvenile cynomolgus macaques. European Society of Gene and Cell Therapy 27th Annual Congress; October 22-25, 2019; Barcelona, Spain."},{"key":"10.1016\/j.omtm.2023.06.001_bib29","first-page":"403","article-title":"Combined CNS and systemic directed gene therapy in a mouse model of Pompe disease with advanced disease at treatment","volume":"28","author":"Hordeaux","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.omtm.2019.08.015","article-title":"Clinical considerations for capsid choice in the development of liver-targeted AAV-based gene transfer","volume":"15","author":"Pipe","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.06.001_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.06.001_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12887-015-0459-8","article-title":"Application of the Gross Motor Function Measure-66 (GMFM-66) in Dutch clinical practice: a survey study","volume":"15","author":"Beckers","year":"2015","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.omtm.2023.06.001_bib33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2522\/ptj.20070314","article-title":"Reference curves for the Gross Motor Function Measure: percentiles for clinical description and tracking over time among children with cerebral palsy","volume":"88","author":"Hanna","year":"2008","journal-title":"Phys. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2522\/ptj.20110374","article-title":"Reliability and responsiveness of the gross motor function measure-88 in children with cerebral palsy","volume":"93","author":"Ko","year":"2013","journal-title":"Phys. Ther."},{"key":"10.1016\/j.omtm.2023.06.001_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/archdischild-2020-319063","article-title":"How to use the Bayley Scales of Infant and Toddler Development","volume":"106","author":"Del Rosario","year":"2021","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"10.1016\/j.omtm.2023.06.001_bib36","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/acs.analchem.7b04590","article-title":"Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein\u00a0Biomarker for the Rare Disease Friedreich's Ataxia","volume":"90","author":"Guo","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.omtm.2023.06.001_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinorgbio.2018.03.007","article-title":"Interactions of iron-bound frataxin with ISCU and ferredoxin on the cysteine desulfurase complex leading to Fe-S cluster assembly","volume":"183","author":"Cai","year":"2018","journal-title":"J.\u00a0Inorg. Biochem."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:36:33Z","timestamp":1714786593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123000918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":37,"alternative-id":["S2329050123000918"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.06.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023","name":"copyright","label":"Copyright"}]}}